|
⚲
|
| Keyboard |
| Fox Christine
✚
|
|
|---|---|
| CIK # | 0001998173 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001998173] | |
| 4 | [0001998173] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Fox Christine | |
| Teva Pharmaceutical Industries Ltd |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Teva Pharmaceutical Industries Ltd TEVA
Restricted Share Units · derivative
|
2026-03-05 | Option exercise | 17,819 | $0.00 | |
|
Teva Pharmaceutical Industries Ltd TEVA
Ordinary Shares
|
2026-03-05 | Sell | 7,924 | $31.67 | 250,953 |
|
Teva Pharmaceutical Industries Ltd TEVA
Ordinary Shares
|
2026-03-05 | Option exercise | 17,819 | ||
|
Teva Pharmaceutical Industries Ltd TEVA
Restricted Share Units · derivative
|
2026-03-04 | Grant | 50,643 | $0.00 | |
|
Teva Pharmaceutical Industries Ltd TEVA
Ordinary Shares
|
2026-03-04 | Option exercise | 20,461 | ||
|
Teva Pharmaceutical Industries Ltd TEVA
Ordinary Shares
|
2026-03-04 | Sell | 9,098 | $32.46 | 295,321 |
|
Teva Pharmaceutical Industries Ltd TEVA
Restricted Share Units · derivative
|
2026-03-04 | Option exercise | 20,461 | $0.00 | |
|
Teva Pharmaceutical Industries Ltd TEVA
Ordinary Shares
|
2025-11-20 | Sell | 28,229 | $24.78 | 699,515 |
|
Teva Pharmaceutical Industries Ltd TEVA
Ordinary Shares
|
2025-11-20 | Option exercise | 63,492 | ||
|
Teva Pharmaceutical Industries Ltd TEVA
Restricted Share Units · derivative
|
2025-11-20 | Option exercise | 63,492 | $0.00 | |
|
Teva Pharmaceutical Industries Ltd TEVA
Ordinary Shares
|
2025-11-14 | Sell | 30,000 | $25.11 | 753,300 |
|
Teva Pharmaceutical Industries Ltd TEVA
Ordinary Shares
|
2025-03-05 | Sell | 2,147 | $15.91 | 34,159 |
|
Teva Pharmaceutical Industries Ltd TEVA
Restricted Share Units · derivative
|
2025-03-05 | Grant | 71,278 | $0.00 | |
|
Teva Pharmaceutical Industries Ltd TEVA
Ordinary Shares
|
2025-03-04 | Option exercise | 20,461 | ||
|
Teva Pharmaceutical Industries Ltd TEVA
Ordinary Shares
|
2025-03-04 | Sell | 4,034 | $15.73 | 63,455 |
|
Teva Pharmaceutical Industries Ltd TEVA
Restricted Share Units · derivative
|
2025-03-04 | Option exercise | 20,461 | $0.00 | |
|
Teva Pharmaceutical Industries Ltd TEVA
Ordinary Shares
|
2024-11-20 | Option exercise | 63,492 | ||
|
Teva Pharmaceutical Industries Ltd TEVA
Ordinary Shares
|
2024-11-20 | Sell | 19,388 | $16.87 | 327,076 |
|
Teva Pharmaceutical Industries Ltd TEVA
Restricted Share Units · derivative
|
2024-11-20 | Option exercise | 63,492 | $0.00 | |
|
Teva Pharmaceutical Industries Ltd TEVA
Restricted Share Units · derivative
|
2024-03-04 | Grant | 81,845 | $0.00 | |
| showing 20 of 21 most recent transactions | |||||